Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Inclusion Criteria: * Hospitalized patients with signs and symptoms suggestive of systemic staphylococcal infection as defined in the protocol * Female patients must be postmenopausal (for at least 1 year), surgically sterile or practicing an effective method of birth control, male partner sterilization or, at the discretion of the investigator, abstinence, before entry and throughout the study and have a negative urine pregnancy test (confirmed with a negative serum pregnancy test) at screening. Exclusion Criteria: * Female patients who are pregnant or lactating * Known or suspected hypersensitivity to beta-lactam antibiotics or any other study medications * Receipt of vancomycin or other antistaphylococcal drug for \> 2 calendar days prior to initiation of study drug * Diagnosis of a catheter-related GPC-cl bacteremia at the time of study enrollment * Clinical findings of left-sided endocarditis prior to enrollment or any time during study participation * Requirement for surgery during the seven days of study therapy administration with the exception of surgery required to manage a complication of S. aureus bacteremia